ArticleJournal of thoracic disease2016
Ceritinib in second and further lines of therapy in advanced ALK mutant adenocarcinoma.
György LosonczyPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleJournal of thoracic disease2016
György LosonczyPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.